Congress Park Capital LLC Cuts Holdings in CytomX Therapeutics, Inc. (NASDAQ:CTMX)
MarketBeat
Congress Park Capital LLC reduced its stake in shares of CytomX Therapeutics, Inc. (NASDAQ:CTMX - Free Report) by 30.2% in the first quarter, according to its most recent filing with the SEC. The fund owned 673,686 shares of the biotechnology company's stock after selling 290,904 shares during the
NASDAQ:CTMX